Rockefeller Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-3,815
Closed -$208K – 2058
2023
Q1
$208K Buy
3,815
+1,110
+41% +$64.8K ﹤0.01% 1802
2022
Q4
$169K Sell
2,705
-563
-17% -$37.4K ﹤0.01% 1745
2022
Q3
$230K Buy
3,268
+2,760
+543% +$190K ﹤0.01% 1592
2022
Q2
$28K Hold
508
– – ﹤0.01% 2562
2022
Q1
$31K Hold
508
– – ﹤0.01% 2536
2021
Q4
$28K Sell
508
-33
-6% -$2.02K ﹤0.01% 2484
2021
Q3
$35K Buy
541
+8
+2% +$546 ﹤0.01% 2319
2021
Q2
$33K Sell
533
-807
-60% -$47.6K ﹤0.01% 2263
2021
Q1
$80K Buy
+1,340
New +$72.9K ﹤0.01% 1705
2020
Q1
– Sell
-200
Closed -$6K – 2512
2019
Q4
$6K Hold
200
– – ﹤0.01% 1759
2019
Q3
$5K Hold
200
– – ﹤0.01% 1649
2019
Q2
$8K Hold
200
– – ﹤0.01% 1333
2019
Q1
$5K Buy
+200
New +$3.63K ﹤0.01% 1644

Other funds holding AXNX

Rockefeller Capital Management's AXNX Position: Q2 2023 in Review

Rockefeller Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 3,815 shares — an estimated $208K sold.

Rockefeller Capital Management first reported a position in AXNX in Q1 2019 and held it in 13 quarters. The position peaked at $230K in Q3 2022. 234 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

  • Rockefeller Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 3,815 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $208K.
  • Rockefeller Capital Management first reported a position in Axonics, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • Rockefeller Capital Management's Axonics, Inc. Common Stock position peaked at $230K in Q3 2022.
  • 234 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on Rockefeller Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.